Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10568762 Stent for treating ocular disorders

Patent 10568762 was granted and assigned to Glaukos (company) on February, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Glaukos (company)
Glaukos (company)
Date Filed
April 23, 2019
Date of Patent
February 25, 2020
Patent Applicant
Glaukos (company)
Glaukos (company)
Patent Application Number
16392534
Patent Citations
‌
US Patent 10285856 Implant delivery system and methods thereof for treating ocular disorders
Patent Citations Received
‌
US Patent 11992551 Implants with controlled drug delivery features and methods of using same
0
‌
US Patent 11925578 Drug delivery implants with bi-directional delivery capacity
0
‌
US Patent 11944573 System and method for delivering multiple ocular implants
0
‌
US Patent 11523938 Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye
‌
US Patent 11559430 Glaucoma stent and methods thereof for glaucoma treatment
‌
US Patent 11564833 Punctal implants with controlled drug delivery features and methods of using same
‌
US Patent 11019996 Gonioscopic devices
‌
US Patent 11019997 Gonioscopic devices
‌
US Patent 11253394 Controlled drug delivery ocular implants and methods of using same
‌
US Patent 11744458 Gonioscopes
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10568762
Patent Primary Examiner
‌
Leslie R Deak

Find more entities like US Patent 10568762 Stent for treating ocular disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.